Pharmacy Times

DECEMBER 24, 2023

From newsworthy moments to groundbreaking research, these were the most-read student-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 26, 2023

From newsworthy moments to groundbreaking research, these were the most-read cardiovascular-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 27, 2023

From newsworthy moments to groundbreaking research, these were the most-read reimbursement-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 27, 2023

From newsworthy moments to groundbreaking research, these were the most-read pneumococcal-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 28, 2023

From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 25, 2023

From newsworthy moments to groundbreaking research, these were the most-read biosimilar-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 26, 2023

From newsworthy moments to groundbreaking research, these were the most-read Clostridioides difficile-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 29, 2023

From newsworthy moments to groundbreaking research, these were the most-read health systems-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 26, 2023

From newsworthy moments to groundbreaking research, these were the most-read heart failure-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 27, 2023

From newsworthy moments to groundbreaking research, these were the most-read skin cancer-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 23, 2023

From newsworthy moments to groundbreaking research, these were the most-read respiratory syncytial virus-related articles on Pharmacy Times in 2023.

65

65

PharmaVoice

DECEMBER 22, 2023

A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.

52

52

The Checkup by Singlecare

DECEMBER 7, 2023

Here are the 5 top health and wellness posts of 2023, based on what pharmacy professionals read most. What pharmacists should know about the blockbuster drugs of 2023 Blockbuster drugs are medications that generate significant annual revenue ($1 billion or more) for pharmaceutical companies. Read more here.

Controlled Substances 52

Controlled Substances Pharmaceutical Companies Pharmaceutical Companies FDA 52

Drug Topics

AUGUST 31, 2023

Your monthly roundup of the top news from Drug Topics®.

123

123

Pharmaceutical Commerce

DECEMBER 29, 2023

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

Packaging 52

Packaging 52

European Pharmaceutical Review

JANUARY 29, 2024

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. During August 2023 the FDA also updated its guidance for NDSRIs 7 and it was closely aligned (but not identical) to EMA’s evolving guidance.

FDA 96

FDA Vaccines Compounding 96

The Checkup by Singlecare

DECEMBER 6, 2023

In 2023, medications like Ozempic , Mounjaro , and Wegovy soared in popularity—so much so that many pharmacies faced a shortage. Read on to see what readers cared about the most in 2023. Read on to see what readers cared about the most in 2023. See what articles made the list. Read the full article here.

Labelling 105

Labelling Hospitals FDA 105

Pharmaceutical Commerce

DECEMBER 26, 2023

Items in this sector ranged touched on topics such as pharma shipping, container technology, and sustainability.

52

52

STAT

JULY 18, 2023

This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.”   Read the rest…

98

98

European Pharmaceutical Review

SEPTEMBER 7, 2023

A key part of Annex 1, due to come into effect on 25 August 2023, is the development of a holistic contamination control strategy (CCS). In this article, EPR’s Caroline Peachey summarises an expert panel discussion, which explored common challenges in implementing a CCS and made several recommendations.

92

92

STAT

DECEMBER 29, 2023

Below, you’ll find our top six most-read articles of the year by page views. And if your holiday plans mean you’re spending some time traveling, be sure to catch up with the “ First Opinion Podcast ,” where I speak with authors of recent First Opinion essays about their articles — and much more.

103

103

European Pharmaceutical Review

NOVEMBER 9, 2023

Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. We also explore opportunities for outsourcing of regulatory activities, the challenges of paediatric drug formulation and much more.

80

80

European Pharmaceutical Review

FEBRUARY 22, 2023

Computed tomography for in-depth investigation of freeze-dried products In this article, Teresa Siegert and Henning Gieseler, discuss the benefits of applying computed tomography in the production of freeze-dried pharmaceutical products, as well as the hurdles that must be navigated to realise its potential.

81

81

Med Ed 101

DECEMBER 18, 2022

The 2023 BCPS exam will not undergo significant changes compared to 2022. There are no planned changes to the content outline for 2023. In this article, I will outline previous pass rates, […]. The post 2023 BCPS Exam – What You Need To Know appeared first on Med Ed 101.

52

52

The Honest Apothecary

MAY 3, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. All article shared will be free to read and not locked behind an annoying paywall. The post Pharma á la carte – 05/04/2023 appeared first on The Honest Apothecary. ” MENTAL FLOSS.

Specialty Pharmacies 105

Specialty Pharmacies Insurance Hospitals 105

DiversifyRx

JANUARY 18, 2024

Get ready to explore the top Pharmacy Team Development articles of 2023 tailored for Independent Pharmacies. Let’s get you caught up on our most popular pharmacy team development blogs from 2023. The post Best of 2023: Pharmacy Team Development first appeared on DiversifyRx. Rest assured, we’ve got your back!

Independent Pharmacies 52

Independent Pharmacies 52

Digital Pharmacist

AUGUST 21, 2023

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. 2023 Flu Vaccination Changes As we look at the 2023-2024 flu season, what’s new for this year?

Vaccines 98

Vaccines Communication Immunization 98

European Pharmaceutical Review

FEBRUARY 2, 2023

The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. Three categories were available for entry in the Exhibitor Innovations section.

Packaging 79

Packaging Medication Delivery 79

The Thyroid Pharmacist

DECEMBER 16, 2022

My sweet son didn’t sleep through the night until he was almost three (and inspired my deep dive research into how to resolve sleep issues, which I shared in my article Sleep Solutions for Hashimoto’s ). We are hoping to feel more settled in 2023. Boy, was I wrong! Stay tuned for announcements in mid-January.

Immunization 62

Immunization Dosage 62

Fuld

FEBRUARY 15, 2023

Join us to better understand and interpret cultural differences and learn how to ensure that your cross-cultural research is delivering unbiased results We also recently published an informative article on Marketing Analytics. Read more… The post February Newsletter 2023 appeared first on Fuld & Co.

52

52

Fuld

JULY 27, 2023

In our second article, we voyage into the $14 billion market of electric vessels. Next, we revisit the highlights from Collision Conference 2023, where the power and perils of Artificial Intelligence were debated. Read more… Get in touch with Amie The post Newsletter – July 2023 appeared first on Fuld & Co.

52

52

Fuld

NOVEMBER 13, 2023

Each article provides a concise, strategic viewpoint designed to inform and guide your business decisions. Our analysis extends to the potential impact of recent geopolitical tensions in the Middle East on the oil markets, a vital concern for all sectors.

Documentation 52

Documentation 52

pharmaphorum

JANUARY 19, 2023

With a new year comes an opportunity for professionals in the healthcare industry to evaluate goals and initiatives for 2023. In this article, I’ll outline some of the challenges that I anticipate for 2023. The post 2023 predictions and challenges in the healthcare business appeared first on.

Health and Personal Care Stores 97

Health and Personal Care Stores Communication HIPAA Patient Care 97

Fuld

JUNE 9, 2023

In our featured articles, we discuss Amazon’s potential as a disruptor in the primary care sector, the current state of private equity exits during challenging times, and the impact of the EPA’s push for stricter emission standards. Read more… Join us at Collision 2023 in Toronto!

Vaccines 52

Vaccines 52

Pharmaceutical Technology

MAY 26, 2023

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

Packaging 52

Packaging 52

European Pharmaceutical Review

MARCH 2, 2023

This article explores some of the most notable developments of 2022, and areas that are likely to be a growing focus for data-driven transformation in 2023. EU Clinical Trial Information System From February 2023 all new clinical trials applications must be submitted via the new portal.

FDA 83

FDA 83

The FDA Law Blog

OCTOBER 16, 2023

Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products.

Documentation 119

Documentation FDA 119